Christinah Mukandavire
Biographic Data
| ID | 9803948 |
|---|---|
| NAME | Christinah Mukandavire |
| GIVEN NAMES | Christinah |
| FAMILY NAME | Mukandavire |
| SIGNATURE | MUKANDAVIRE C |
| AFFILIATIONS | Coalition for Epidemic Preparedness Innovations, London, UK |
| ORCID | 0000-0003-2524-3917 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Covid-19 vaccination implementation in 52 African countries
INTRODUCTION: To end the COVID-19 pandemic, the WHO set a goal in 2021 to fully vaccinate 70% of the global population by mid-2022. We projected the COVID-19 vaccination trajectory in 52 African countries and compared the projected to the 'actual' or 'observed' coverage as of December 2022. We also estimated the required vaccination speed needed to have attained the WHO 70% coverage target by December 2022. METHODS: We obtained publicly available…
The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countries
INTRODUCTION: One in two patients developing tuberculosis (TB) in low-income and middle-income countries (LMICs) faces catastrophic household costs. We assessed the potential financial risk protection from introducing novel TB vaccines, and how health and economic benefits would be distributed across income quintiles. METHODS: We modelled the impact of introducing TB vaccines meeting the World Health Organization preferred product characteristics…
No prominent works on this page.
Covid-19 vaccination implementation in 52 African countries
INTRODUCTION: To end the COVID-19 pandemic, the WHO set a goal in 2021 to fully vaccinate 70% of the global population by mid-2022. We projected the COVID-19 vaccination trajectory in 52 African countries and compared the projected to the 'actual' or 'observed' coverage as of December 2022. We also estimated the required vaccination speed needed to have attained the WHO 70% coverage target by December 2022. METHODS: We obtained publicly available…
The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countries
INTRODUCTION: One in two patients developing tuberculosis (TB) in low-income and middle-income countries (LMICs) faces catastrophic household costs. We assessed the potential financial risk protection from introducing novel TB vaccines, and how health and economic benefits would be distributed across income quintiles. METHODS: We modelled the impact of introducing TB vaccines meeting the World Health Organization preferred product characteristics…
Economics (2 works) · Environmental health (2 works) · Medicine (2 works) · Political science (2 works) · Vaccine Coverage and Hesitancy (2 works) · Business (1 work) · Cape verde (1 work) · COVID-19 epidemiological studies (1 work) · Demography (1 work) · Developing country (1 work)